SFMN - Oncologie RIV
Version Française
English Version
Computation of contact restriction time
after radionuclide therapy
Established on 18 October 2025
Mandatory elements to be specified
Radiopharmaceutical:
—
Iodine-131-0%-uptake
Iodine-131-5%-uptake
Iodine-131-25%-uptake
Iodine-131-Benign disease
PSMA-177Lu
PSMA-177Lu 6 cures
Radium-223
NET 177Lu
NET 177Lu 4 cures
Microspheres-90Y
Microspheres-166Ho
Lipiodol-131I
MIBG 131I
Synovectomy-90Y
Synovectomy-186Re
Synovectomy-169Er
Choose the radiopharmaceutical
Dose rate at 1m at room exit
Unit: µSv/h
Patient size
*
Unit: cm
Effective half-life and scenario adapted to the patient
Non
Oui
Effective half-life
*
Unit: day(s)
Duration at X m
Unit: time (h)
Distance X
Unit: meter (m)
Duration at 1 m (non-zero value required)
Unit: time (h)
Distance 1m
Unit: meter (m)
Dosimetric constraint
Unit: mSv
Benign thyroid disorders
Non
Oui
clinical Situation of thyroid
TODO: N'intervient pas dans les calculs : suppression ?
Just after surgery
Oligo-metastatic neoplasia
Poly-metastatic neoplasia
Benign Pathologies
Dysthyroidism - Activity administered
Unit: MBq
Dysthyroidism - Iodine uptake
Unit: percent (%)
Pathology
TODO: N'intervient pas dans les calculs : suppression ?
Autonomous nodule - % measured
Autonomous nodule - % estimated
Multinodular goitre - % measured
Multinodular goitre - % estimated
Graves’ disease - % measured
Graves’ disease - % estimated
to be specified (drop-down menu)
Software Version 2.0 (2025-09-02)
Computation of contact restriction time
Retour au CNP-MN
